当前位置: X-MOL 学术J. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Results of a phase 1, dose-finding study of Debio 0123 as monotherapy in adult patients with advanced solid tumors: Safety, pharmacokinetic, and preliminary antitumor activity data.
Journal of Clinical Oncology ( IF 42.1 ) Pub Date : 2024-05-29 , DOI: 10.1200/jco.2024.42.16_suppl.3120
Kyriakos P. Papadopoulos 1 , Manish Sharma 2 , Reinhard Dummer 3 , Ilaria Colombo 4 , Egle Ramelyte 5 , Leigh Seamon 2 , Drew W. Rasco 6 , Victor Rodriguez Freixinos 7 , Vito Dozio 7 , Tri Tat 7 , Noemie Luong 7 , Aliaksandr Hurynovich 7 , Mokhtar Omar 7 , Sandrine Micallef 7 , Anne Bellon 7 , Esteban Rodrigo Imedio 7 , Anastasios Stathis 8
Affiliation  

Journal of Clinical Oncology, Volume 42, Issue 16_suppl, Page 3120-3120, June 2024.


中文翻译:


Debio 0123 作为晚期实体瘤成年患者单一疗法的 1 期剂量探索研究结果:安全性、药代动力学和初步抗肿瘤活性数据。



《临床肿瘤学杂志》,第 42 卷,第 16 期_suppl,第 3120-3120 页,2024 年 6 月。
更新日期:2024-05-30
down
wechat
bug